Zepbound Cost: Every Price Path Compared (2026)

How much does Zepbound actually cost, once you count every path?

There isn't one Zepbound price — there are roughly five, and they don't overlap much. What you land on depends less on where you shop than on a single upstream fact: does your insurance plan consider Zepbound a covered benefit for your situation. Everything downstream of that answer follows a fairly predictable ladder.

• Insured, Zepbound covered, savings card applied — as low as $25 a month, Lilly's best-case scenario
• Uninsured, LillyDirect self-pay — $299 to $449 a month by dose, direct from the manufacturer
• Insured but Zepbound not covered, savings card applied — the same $299–$449 ladder as self-pay
• Retail pharmacy with a GoodRx or SingleCare coupon — commonly $490 to a little over $1,000 a month, wildly variable by zip code
• Full retail list price, no program at all — up to $1,086 a month, the number every other path exists to beat
• Compounded tirzepatide (a related but different product) — roughly $199 to $449 a month through telehealth

The rest of this page walks through each rung of that ladder, plus the two questions that trip people up most: what your insurance will actually pay toward Zepbound, and whether a lower compounded price is really the same drug you think you're buying.

What does LillyDirect self-pay cost, dose by dose?

LillyDirect is Eli Lilly's own direct-to-patient platform, not a discounter reselling someone else's markdown. Through its self-pay program, brand-name Zepbound runs $299 a month at the 2.5mg starter dose, $399 at 5mg, and a flat $449 across every dose from 7.5mg through 15mg. Both the single-dose vial and the KwikPen autoinjector sit on that same ladder now — the format you choose is about needle comfort, not price.

One rule to build a habit around: the discounted price only holds if you complete your next refill within 45 days of your previous shipment's delivery date. Miss it, and the price resets higher for that fill. The full mechanics of that rule, along with a vial-versus-pen breakdown, live on Zepbound without insurance if you want the deeper walkthrough.

Does insurance cover Zepbound, and what's the copay with the savings card?

Zepbound's FDA approval covers three situations: obesity, being overweight with a weight-related condition like high blood pressure or prediabetes, or moderate-to-severe obstructive sleep apnea alongside obesity. Whether your specific plan pays toward it is a separate question entirely — coverage for obesity medications varies enormously by employer and plan design, and a documented qualifying diagnosis from your prescriber is usually what coverage review actually checks.

If your plan does cover it, Lilly's savings card is where the real savings show up. Commercially insured patients with Zepbound on formulary can pay as little as $25 for a fill, capped at a few hundred dollars off per prescription and a yearly maximum. If your commercial plan technically covers weight-management drugs but excludes Zepbound specifically, the same card drops you to the $299–$449 self-pay ladder instead of full list price — worth enrolling even if you assume you won't qualify for the best tier.

Medicare is the harder case. Federal law has historically barred Medicare from paying for weight-loss drugs outright, which meant Zepbound prescribed for obesity got zero Medicare help regardless of dose or diagnosis. There's reporting of a narrower Medicare GLP-1 pilot program surfacing in 2026 that would offer a flat copay for a limited set of GLP-1 medications, including the Zepbound KwikPen, to beneficiaries who meet a BMI threshold or have a qualifying condition — but as of this writing that program is very new and still being rolled out, so treat any specific detail as provisional and confirm your own eligibility directly rather than assuming it applies.

Is compounded Zepbound cheaper — and is it actually Zepbound?

It isn't Zepbound, first of all — a distinction worth sitting with before the price comparison. Zepbound is Lilly's FDA-approved, finished-drug brand. "Compounded Zepbound" or "compounded tirzepatide" refers to the same active molecule mixed by a licensed 503A pharmacy for an individual patient, which has never gone through the same finished-product review Zepbound underwent.

The legal footing shifted hard in 2025. Once the FDA declared the tirzepatide shortage resolved, the broad compounding that fueled a wave of cheap telehealth tirzepatide lost its basis. What survives now is narrower: a 503A pharmacy can still compound tirzepatide for a specific patient when a prescriber documents a clinical reason the commercial product doesn't meet — cost alone doesn't qualify under current FDA guidance, even though cost is the reason most people are drawn to it. There's also a pending regulatory step layered on top: the FDA proposed removing tirzepatide from the 503B bulk-substances list, and as of this writing that comment period is still open rather than finalized — confirm the current status before treating either the broader legality or the narrower exception as settled.

For the actual dollar figures, compounded tirzepatide runs roughly $199 to $449 a month depending on the provider and whether you choose an oral or injectable format. Rather than re-listing that roster here, see compounded tirzepatide providers compared for the full price and legal breakdown, or Zepbound vs. tirzepatide if you want the terminology sorted out in more depth.

What does Zepbound cost through LifeMD?

LifeMD is a publicly traded telehealth company, not a compounding pharmacy, and it prices Zepbound in two separate pieces that are easy to conflate. There's a membership fee for the clinical program itself — clinician visits, insurance benefits checks, ongoing follow-up. Separately, and not included in that membership number, sits the medication itself. For patients with coverage, LifeMD's team checks what your plan pays and what your copay looks like, sometimes landing quite low. For cash-pay patients without coverage, the medication runs on the same LillyDirect self-pay ladder described above, since LifeMD works as a connected telehealth partner rather than an independent pricing source for the drug itself.

The practical takeaway: a LifeMD quote for Zepbound is really two numbers stacked, membership plus medication, and it's worth asking for both broken out before you enroll rather than anchoring on whichever figure appears first on the landing page.

Mounjaro vs. Zepbound — is one actually cheaper than the other?

Same molecule, tirzepatide, sold under two brand names with two separate FDA approvals — Mounjaro for type 2 diabetes, Zepbound for chronic weight management — and that single regulatory split is why their prices don't track each other. Mounjaro's retail list price runs close to $1,088 a month regardless of dose, and its own Lilly savings card splits into a $25 tier for insured patients whose plan covers it and roughly $499 for insured patients whose plan doesn't. There is no LillyDirect self-pay vial program for the Mounjaro brand itself — that discount structure belongs to Zepbound.

That asymmetry matters most for anyone whose prescription is written for weight management rather than diabetes, which describes a lot of women navigating perimenopause-related metabolic shifts. A Mounjaro coupon or Mounjaro's assistance programs don't transfer to a Zepbound prescription, and vice versa — if weight management is the documented reason on your script, you're working inside Zepbound's pricing and coverage rules, not Mounjaro's, even though the injection and the manufacturer are identical. For the full nine-way Mounjaro price breakdown, see Mounjaro cost.

What if you skip every program — retail and GoodRx pricing

Retail pricing for Zepbound is genuinely inconsistent, and it's worth knowing that going in rather than being surprised by a quote that doesn't match what you read online. Reported GoodRx and SingleCare coupon prices for Zepbound have ranged from roughly $490 a month at some pharmacies up to a little over $1,000 at others, depending on location and which discount network the pharmacy participates in that month. Lilly's own pricing agreements with third-party coupon programs tend to keep the discount shallow, so a coupon price is frequently close to the pharmacy's regular cash rate rather than a meaningful markdown.

Full list price, with no program of any kind, sits at the top of the range — the KwikPen lists at just over $1,086 regardless of dose. That's the number worth actively avoiding by checking LillyDirect, your savings card eligibility, or a compounded option before you fill anything at that rate.

Annual cost math: insured vs. LillyDirect vs. compounded vs. retail

• Insured, savings card, covered: about $300 a year ($25 a month)
• LillyDirect self-pay, 5mg tier: about $4,788 a year ($399 a month)
• LillyDirect self-pay, 7.5–15mg maintenance: about $5,388 a year ($449 a month)
• Compounded tirzepatide, low to high verified range: roughly $2,388 to $5,388 a year, depending on provider and dose
• Retail, no program at all: roughly $5,880 to $13,000 a year, the range every other path is designed to beat

The gap between the best-case insured year and the uncovered retail year runs into the thousands — which is the entire reason it's worth confirming your coverage and savings-card eligibility before your very first fill, not after.

How to choose, and the red flags worth watching for

A few patterns are worth treating as hard stops regardless of which path you're leaning toward. Any seller offering tirzepatide or Zepbound without requiring a prescription or a clinician evaluation is not operating legally, and that's a real counterfeit and dosing-error risk, not just a technicality. Pricing on brand-name Zepbound meaningfully below the $299 floor is a sign you're not looking at the real product, since that floor is Lilly's own manufacturer rate. And for compounded options specifically, a legitimate provider should be able to tell you which 503A pharmacy fills the prescription, whether it carries PCAB accreditation, and how your prescriber documents the specific clinical reason for compounding rather than treating cost as the justification.

• LillyDirect fits you if: you want the FDA-approved brand and can manage the 45-day refill discipline
• The savings card fits you if: you have commercial insurance — check both the covered and non-covered tiers, since either beats paying full retail
• Compounded tirzepatide fits you if: cost is the binding constraint and you've read the compounded provider comparison rather than the first ad you saw
• None of the above fits you if: a seller skips the prescription step, or a compounded provider can't answer basic questions about its pharmacy's licensing